Identification of a risk haplotype of the α-synuclein gene in Japanese with sporadic Parkinson's disease

Movement Disorders

Volumn 21, Issue 12, 2006, Pages 2157-2164

  Kobayashi, Hideaki ^a   Ujike, Hiroshi ^b   Hasegawa, Junko ^c   Yamamoto, Mitsutoshi ^d   Kanzaki, Akihiro ^e   Sora, Ichiro ^a,c  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^d Kagawa Prefectural Central Hospital   (Japan)

^e HIROSHIMA CITY HOSPITAL   (Japan)

Author keywords

Association; Genetics; Japanese; Parkinson's disease; Synuclein

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; JAPAN; LEWY BODY; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PARKINSON DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALPHA-SYNUCLEIN; CONFIDENCE INTERVALS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; PARKINSON DISEASE; POLYMORPHISM, GENETIC; RISK;

EID: 33846462040     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21142     Document Type: Article

References (51)

1. Spillantini MG, Crowther RA, Jakes R, Hasegawa M, Goedert M. Alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies. Proc Natl Acad Sci U S A 1998;95:6469-6473.
2. Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q2l-q23. Science 1996;274:1197-1199.
3. Gasser T, Muller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998;18:262-265.
4. Sveinbjornsdottir S, Hicks AA, Jonsson T, et al. Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 2000;343: 1765-1770.
5. Polymeropoulos MH. Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047.
6. Papadimitriou A, Veletza V, Hadjigeorgiou GM, Patrikiou A, Hirano M, Anastasopoulos I. Mutated alpha-synuclein gene in two Greek kindreds with familial PD: incomplete penetrance? Neurology 1999;52:651-654.
7. Athanassiadou A, Voutsinas G, Psiouri L, et al. Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. Am J Hum Genet 1999;65: 555-558.
8. Markopoulou K, Wszolek ZK, Pfeiffer RF, Chase BA. Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism. Ann Neurol 1999;46:374-381.
9. Kruger R, Kuhn W, Muller T, et al. Ala3OPro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 1998; 18:106-108.
10. Munoz E, Oliva R, Obach V, et al. Identification of Spanish familial Parkinson's disease and screening for the Ala53Thr mutation of the alpha-synuclein gene in early onset patients. Neurosci Lett 1997;235:57-60.
11. Chan P, Tanner CM, Jiang X, Langston JW. Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. Neurology 1998;50:513-514.
12. Farrer M, Wavrant-De Vrieze F, Crook R, et al. Low frequency of alpha-synuclein mutations in familial Parkinson's disease. Ann Neurol 1998;43:394-397.
13. Wang WW, Khajavi M, Patel BJ, Beach J, Jankovic J, Ashizawa T. The G209A mutation in the alpha-synuclein gene is not detected in familial cases of Parkinson disease in non-Greek and/or Italian populations. Arch Neurol 1998;55:1521-1523.
14. El-Agnaf OM, Curran MD, Wallace A, et al. Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. Neuroreport 1998;9:3925-3927.
15. Higuchi S, Arai H, Matsushita S, et al. Mutation in the alpha-synuclein gene and sporadic Parkinson's disease, Alzheimer's disease, and dementia with Lewy bodies. Exp Neurol 1998;153:164-166.
16. Warner TT, Schapira AH. The role of the alpha-synuclein gene mutation in patients with sporadic Parkinson's disease in the United Kingdom. J Neurol Neurosurg Psychiatry 1998;65:378-379.
17. Lin JJ, Yueh KC, Chang DC, Lin SZ. Absence of G209A and G88C mutations in the alpha-synuclein gene of Parkinson's disease in a Chinese population. Eur Neurol 1999;42:217-220.
18. Chan DK, Mellick G, Cai H, et al. The alpha-synuclein gene and Parkinson disease in a Chinese population. Arch Neurol 2000;57: 501-503.
19. Singleton AB, Farrer M, Johnson J, et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science 2003;302:841.
20. Chartier-Harlin MC, Kachergus J, Roumier C, et al. Alpha-synuclein locus duplication as a cause of familial Parkinson's disease. Lancet 2004;364:1167-1169.
21. Ibanez P, Bonnet AM, Debarges B, et al. Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet 2004;364:1169-1171.
22. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and alpha-synuclein genomic multiplications. Ann Neurol 2004;55:174-179.
23. Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 2000;287:1265-1269.
24. Johnson J, Hague SM, Hanson M, et al. SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies. Neurology 2004;63:554-556.
25. Hope AD, Myhre R, Kachergus J, et al. Alpha-synuclein missense and multiplication mutations in autosomal dominant Parkinson's disease. Neurosci Lett 2004;367:97-100.
26. Gispert S, Trenkwalder C, Mota-Vieira L, Kostic V, Auburger G. Failure to find alpha-synuclein gene dosage changes in 190 patients with familial Parkinson disease. Arch Neurol 2005;62:96-98.
27. Touchman JW, Dehejia A, Chiba-Falek O, et al. Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. Genome Res 2001; 11:78-86.
28. Tan EK, Khajavi M, Thomby JI, Nagamitsu S, Jankovic J, Ashizawa T. Variability and validity of polymorphism association studies in Parkinson's disease. Neurology 2000;55:533-538.
29. Farrer M, Maraganore DM, Lockhart P, et al. Alpha-Synuclein gene haplotypes are associated with Parkinson's disease. Hum Mol Genet 2001; 10: 1847-1851.
30. Parsian A, Racette B, Zhang ZH, et al. Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease. Neurology 1998;51:1757-1759.
31. Kruger R, Vieira-Saecker AM, Kuhn W, et al. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/ apolipoprotein E genotype. Ann Neurol 1999;45: 611-617.
32. Izumi Y, Morino H, Oda M, et al. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan. Neurosci Lett 2001;300:125-127.
33. Khan N, Graham E, Dixon P, et al. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann Neurol 2001;49:665-668.
34. Tan EK, Tan C, Shen H, et al. Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability. Neurosci Lett 2003;336:70-72.
35. Tan EK, Chai A, Teo YY, et al. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease. Neurology 2004;62:128-131.
36. Ujike H, Yamamoto M, Kanzaki A, Okumura K, Takaki M, Kuroda S. Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson's disease. Mov Disord 2001;16:111-113.
37. Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 1999;56:33-39.
38. Schneider S, Roessli D, Excoffier L. Arlequin: a software for population genetics data analysis. Ver 2.000. Genetics and Biometry Lab, Department of Anthropology, University of Geneva; 2000.
39. Holzmann C, Kruger R, Saecker AM, et al. Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease. J Neural Transm 2GO3; 110:67-76.
40. Xia Y, Saitoh T, Ueda K, et al. Characterization of the human alpha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms. J Alzheimers Dis 2001;3: 485-494.
41. Autere JM, Hiltunen MJ, Mannermaa AJ, et al. Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland. Eur J Neurol 2002;9:479-483.
42. Mueller JC, Fuchs J, Hofer A, et al. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann Neurol 2005;57:535-541.
43. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392:605-608.
44. Valente EM, Abou-Sleiman PM, Caputo V, et al. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 2004;304:1158-1160.
45. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism. Science 2003;299:256-259.
46. Gasser T. Genetics of Parkinson's disease. Curr Opin Neurol 2005;18:363-369.
47. Rogaeva E, Johnson J, Lang AE, et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol 2004;61:1898-1904.
48. Valente EM, Salvi S, Ialongo T, et al. PINK1 mutations are associated with sporadic early-onset parkinsonism. Ann Neurol 2004;56:336-341.
49. Clark LN, Afridi S, Mejia-Santana H, et al. Analysis of an early-onset Parkinson's disease cohort for DJ-1 mutations. Mov Disord 2004;19:796-800.
50. Healy DG, Abou-Sleiman PM, Valente EM, et al. DJ-1 mutations in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004;75: 144-145.
51. Hedrich K, Djarmati A, Schafer N, et al. DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology 2004;62:389-394.